Top

Lung

Published in:

01-10-2016

HIF-1-Dependent TGM1 Expression is Associated with Maintenance of Airway Epithelial Junction Proteins

Authors: Lili Li, Chris J. Watson, Mickael Dubourd, Aine Bruton, Maojia Xu, Gordon Cooke, John A. Baugh

Published in: Lung | Issue 5/2016

Abstract

Introduction

Hypoxia has been implicated in the pathogenesis of many inflammatory and fibrotic lung diseases. The effect of hypoxia on epithelial junction protein expression is yet to be fully elucidated but evidence suggests a protective role for the hypoxia-inducible transcription factor HIF-1 in stabilising occludin. Transglutaminase 1 (TGM1) has been shown to stabilise endothelial and keratinocyte cell junctions, and while its expression and function have been mostly studied in the skin, recent studies have reported its expression in the lung. We hypothesised that TGM1 is a hypoxia-induced regulator of pulmonary epithelial junction protein stability, and the aim of this study was to investigate the regulation of TGM1 expression by hypoxia.

Methods

Hypoxia-responsive genes were identified in human small airway epithelial cells (SAECs) by DNA microarray. TGM1 mRNA expression in SAECs was measured by quantitative real-time PCR. Protein expression of TGM1 and junction proteins was investigated by western blotting. Hypoxia-induced TGM1 was analysed by immunohistochemistry in vivo. The TGM1 gene promoter was investigated by luciferase assay.

Results

In vitro exposure of SAECs to hypoxia induced a significant increase in TGM1 expression at both mRNA and protein levels. TGM1 was also significantly upregulated in hypoxic mouse lung epithelium. The hypoxia-responsive region was mapped to a HIF-1-responsive element. Inhibition of HIF-1 expression abolished hypoxia-induced promoter activation. Overexpression of TGM1 in lung epithelial cells or exposure of SAECs to hypoxia led to upregulated expression of junction proteins.

Conclusion

Herein we report that TGM1 is a HIF-1-regulated gene that is associated with the upregulation of airway epithelial junction proteins, supporting a protective role for HIF-1 in the lung. Interventions that augment the expression of TGM1 may provide useful therapeutic strategies for maintaining pulmonary epithelial integrity during lung injury.

Available only for authorised users

Dada LA, Chandel NS, Ridge KM et al (2003) Hypoxia-induced endocytosis of Na, K-ATPase in alveolar epithelial cells is mediated by mitochondrial reactive oxygen species and PKC-zeta. J Clin Invest 111(7):1057–1064. doi:10.1172/JCI16826 CrossRefPubMedPubMedCentral

Planes C, Friedlander G, Loiseau A et al (1996) Inhibition of Na-K-ATPase activity after prolonged hypoxia in an alveolar epithelial cell line. Am J Physiol 271(1 Pt 1):L70–L78PubMed

Wodopia R, Ko HS, Billian J et al (2000) Hypoxia decreases proteins involved in epithelial electrolyte transport in A549 cells and rat lung. Am J Physiol Lung Cell Mol Physiol 279(6):L1110–L1119PubMed

Bouvry D, Planes C, Malbert-Colas L et al (2006) Hypoxia-induced cytoskeleton disruption in alveolar epithelial cells. Am J Respir Cell Mol Biol 35(5):519–527. doi:10.1165/rcmb.2005-0478OC CrossRefPubMed

Caraballo JC, Yshii C, Butti ML et al (2011) Hypoxia increases transepithelial electrical conductance and reduces occludin at the plasma membrane in alveolar epithelial cells via PKC-zeta and PP2A pathway. Am J Physiol Lung Cell Mol Physiol 300(4):L569–578. doi:10.1152/ajplung.00109.2010 CrossRefPubMedPubMedCentral

Olson N, Hristova M, Heintz NH et al (2011) Activation of hypoxia-inducible factor-1 protects airway epithelium against oxidant-induced barrier dysfunction. Am J Physiol Lung Cell Mol Physiol 301(6):L993–L1002. doi:10.1152/ajplung.00250.2011 CrossRefPubMedPubMedCentral

Ouiddir A, Planes C, Fernandes I et al (1999) Hypoxia upregulates activity and expression of the glucose transporter GLUT1 in alveolar epithelial cells. Am J Respir Cell Mol Biol 21(6):710–718CrossRefPubMed

Simon LM, Robin ED, Raffin T et al (1978) Bioenergetic pattern of isolated type II pneumocytes in air and during hypoxia. J Clin Invest 61(5):1232–1239. doi:10.1172/JCI109039 CrossRefPubMedPubMedCentral

Escoubet B, Planes C, Clerici C (1999) Hypoxia increases glyceraldehyde-3-phosphate dehydrogenase transcription in rat alveolar epithelial cells. Biochem Biophys Res Commun 266(1):156–161. doi:10.1006/bbrc.1999.1798 CrossRefPubMed

10.

Parenteau NL, Pilato A, Rice RH (1986) Induction of keratinocyte type-I transglutaminase in epithelial cells of the rat. Differentiation 33(2):130–141CrossRefPubMed

11.

Martinet N, Bonnard L, Regnault V et al (2003) In vivo transglutaminase type 1 expression in normal lung, preinvasive bronchial lesions, and lung cancer. Am J Respir Cell Mol Biol 28(4):428–435. doi:10.1165/rcmb.2002-0114OC CrossRefPubMed

12.

Baumgartner W, Golenhofen N, Weth A et al (2004) Role of transglutaminase 1 in stabilisation of intercellular junctions of the vascular endothelium. Histochem Cell Biol 122(1):17–25. doi:10.1007/s00418-004-0668-y CrossRefPubMed

13.

Zhang Z, Xing J, Ma L et al (2008) Transglutaminase-1 regulates renal epithelial cell proliferation through activation of Stat-3. J Biol Chem. doi:10.1074/jbc.M808396200

14.

Hiiragi T, Sasaki H, Nagafuchi A et al (1999) Transglutaminase type 1 and its cross-linking activity are concentrated at adherens junctions in simple epithelial cells. J Biol Chem 274(48):34148–34154CrossRefPubMed

15.

Kalinin A, Marekov LN, Steinert PM (2001) Assembly of the epidermal cornified cell envelope. J Cell Sci 114(Pt 17):3069–3070PubMed

16.

Lorand L, Graham RM (2003) Transglutaminases: crosslinking enzymes with pleiotropic functions. Nat Rev Mol Cell Biol 4(2):140–156. doi:10.1038/nrm1014 CrossRefPubMed

17.

Baumgartner W, Weth A (2007) Transglutaminase 1 stabilizes beta-actin in endothelial cells correlating with a stabilization of intercellular junctions. J Vasc Res 44(3):234–240. doi:10.1159/000100422 CrossRefPubMed

18.

Howell K, Preston RJ, McLoughlin P (2003) Chronic hypoxia causes angiogenesis in addition to remodelling in the adult rat pulmonary circulation. J Physiol 547(Pt 1):133–145. doi:10.1113/jphysiol.2002.030676 CrossRefPubMed

19.

Baugh JA, Gantier M, Li L et al (2006) Dual regulation of macrophage migration inhibitory factor (MIF) expression in hypoxia by CREB and HIF-1. Biochem Biophys Res Commun 347(4):895–903. doi:10.1016/j.bbrc.2006.06.148 CrossRefPubMed

20.

Bakker EN, Pistea A, VanBavel E (2008) Transglutaminases in vascular biology: relevance for vascular remodeling and atherosclerosis. J Vasc Res 45(4):271–278. doi:10.1159/000113599 CrossRefPubMed

21.

Cocuzzi ET, Chung SI (1986) Cellular transglutaminase. Lung matrix-associated transglutaminase: characterization and activation with sulfhydryls. J Biol Chem 261(18):8122–8127PubMed

22.

Lee SY, Kim YJ (2003) Role of crosslinked protein in lung injury following total body irradiation and bone marrow transplantation. Exp Mol Med 35(6):565–571CrossRefPubMed

23.

Yamada K, Yamanishi K, Kakizuka A et al (1994) Transcriptional regulation of human transglutaminase1 gene by signaling systems of protein kinase C, RAR/RXR and Jun/Fos in keratinocytes. Biochem Mol Biol Int 34(4):827–836PubMed

24.

Phillips MA, Jessen BA, Lu Y et al (2004) A distal region of the human TGM1 promoter is required for expression in transgenic mice and cultured keratinocytes. BMC Dermatol 4:2. doi:10.1186/1471-5945-4-2 CrossRefPubMedPubMedCentral

25.

Medvedev A, Saunders NA, Matsuura H et al (1999) Regulation of the transglutaminase I gene. Identification of DNA elements involved in its transcriptional control in tracheobronchial epithelial cells. J Biol Chem 274(6):3887–3896CrossRefPubMed

26.

Kellerman PS, Bogusky RT (1992) Microfilament disruption occurs very early in ischemic proximal tubule cell injury. Kidney Int 42(4):896–902CrossRefPubMed

27.

Schwartz N, Hosford M, Sandoval RM et al (1999) Ischemia activates actin depolymerizing factor: role in proximal tubule microvillar actin alterations. Am J Physiol 276(4 Pt 2):F544–F551PubMed

28.

Furuta GT, Turner JR, Taylor CT et al (2001) Hypoxia-inducible factor 1-dependent induction of intestinal trefoil factor protects barrier function during hypoxia. J Exp Med 193(9):1027–1034CrossRefPubMedPubMedCentral

Title: HIF-1-Dependent TGM1 Expression is Associated with Maintenance of Airway Epithelial Junction Proteins
Authors: Lili Li
Chris J. Watson
Mickael Dubourd
Aine Bruton
Maojia Xu
Gordon Cooke
John A. Baugh
Publication date: 01-10-2016
Publisher: Springer US
Published in: Lung / Issue 5/2016
Print ISSN: 0341-2040
Electronic ISSN: 1432-1750
DOI: https://doi.org/10.1007/s00408-016-9918-8

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

HIF-1-Dependent TGM1 Expression is Associated with Maintenance of Airway Epithelial Junction Proteins

Abstract

Introduction

Methods

Results

Conclusion

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Introduction

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 5/2016

Occupational Asthma Due to Inhalation of Aerosolized Lipophilic Coating Materials

Association of Single Nucleotide Polymorphisms of PADI4 and HLA-DRB1 Alleles with Susceptibility to Rheumatoid Arthritis-Related Lung Diseases

Erratum to: Comparison of Pulmonary Involvement Between Patients Expressing Anti-PL-7 and Anti-Jo-1 Antibodies

Increased Mortality in Adult Cystic Fibrosis Patients with Medicaid Insurance Awaiting Lung Transplantation

Respiratory Muscle Assessment in Acute Guillain–Barré Syndrome

The Roles of the Charlson Comorbidity Index and Time to First Antibiotic Dose as Predictors of Outcome in Pneumococcal Community-Acquired Pneumonia

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page